Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123577 · ClinicalTrials.gov registry record · NA
Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices
A NA study, sponsored by New York City Department of Health and Mental Hygiene.
- Completed
- Registry status
- NA
- Development phase
- 899
- Enrollment target
NCT01123577 is a NA study that has completed, run by New York City Department of Health and Mental Hygiene. The registered enrollment target is 899 participants.
The verdict
NCT01123577, a NA study, has completed, sponsored by New York City Department of Health and Mental Hygiene.
- COMPLETED
- Registry status
- NA
- Development phase
- 899 participants
- Enrollment target
Study Summary
Background: Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD), the leading cause of death in the United States and New York City (NYC). One in 4 NYC adults has hypertension, with higher prevalence in both Blacks and Latinos compared to Whites (Angell 2008). In NYC, only 65% of all adults with HTN and on treatment are controlled (Angell 2008). Self-blood pressure monitoring (SBPM) is associated with reduced blood pressure in patients with hypertension (Cappuccio 2004). Studies suggest that SBPM may increase control either by inducing clinicians to titrate medication more actively, (Agency for Healthcare Research and Quality 2002) by engaging patients to participate in their own health care, (Taylor 2007) or a combination of the two. However, minimal research has been done to evaluate the effectiveness of SBPM in different racial and/or ethnic groups or in low income populations or to discern effective patterns of SBPM use by patients. Best practices for integration of self monitoring into HTN into regular treatment have also yet to be established. Objectives: The goal of this study is to assess the impact of SBPM under conditions consistent with existing community health clinic resources and infrastructure in NYC's medically underserved neighborhoods using commonly available automated home BP monitors. By using a community clinic's electronic health record (EHR) and automated BP monitors with the capability to transmit readings to a research database, we can facilitate a more rigorous evaluation of a pilot SBPM intervention and assess patterns of home monitor use and clinical management and their association with outcomes. The three specific aims of this intervention are to: 1. Assess whether use of SBPM reduces elevated BP and increases HTN control to similar levels in two historically understudied minority populations, Blacks and Latinos. 2. Confirm pilot findings by assessing the impact of SBPM on BP and HTN control compared to usua
Interventions
- OTHER Home Blood Pressure Monitor Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 899 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123577
The ClinicalTrials.gov registry entry for NCT01123577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 899 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York City Department of Health and Mental Hygiene, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home Blood Pressure Monitor Group is the first listed.
NCT01123577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123577 about?
NCT01123577 is a clinical study titled "Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices". Background: Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD), the leading cause of death in the United States and New York City (NYC). One in 4 NYC adults has hypertension, with higher prevalence in both Blacks and Latinos compared to Whites (Angell 2008). In NYC, only 65%...
What is the current status of trial NCT01123577?
This trial is currently completed. It is a NA study. The enrollment target is 899 participants. The study started on 2010-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01123577?
The interventions under investigation include: Home Blood Pressure Monitor Group (OTHER).
Who is sponsoring clinical trial NCT01123577?
This trial is sponsored by New York City Department of Health and Mental Hygiene, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.